Cited by 256Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesRadiomics and Machine Learning in Medical Imaging

The DOI matches its Crossref record; 212 of the 216 references it cites were found in a registry or an index.

Assessing the interactions between radiotherapy and antitumour immunity

Open access

Grassberger, Clemens, Ellsworth, Susannah G., Wilks, Moses Q., Keane, Florence K., Loeffler, Jay S.·2019·Nature Reviews Clinical Oncology

DOI 10.1038/s41571-019-0238-9PMC PMC13492067

Open this paper in CoChat — free account

Abstract

Immunotherapy, specifically the introduction of immune checkpoint inhibitors, has transformed the treatment of cancer, enabling long-term tumour control even in individuals with advanced-stage disease. Unfortunately, only a small subset of patients show a response to currently available immunotherapies. Despite a growing consensus that combining immune checkpoint inhibitors with radiotherapy can increase response rates, this approach might be limited by the development of persistent radiation-induced immunosuppression. The ultimate goal of combining immunotherapy with radiotherapy is to induce a shift from an ineffective, pre-existing immune response to a long-lasting, therapy-induced immune response at all sites of disease. To achieve this goal and enable the adaptation and monitoring of individualized treatment approaches, assessment of the dynamic changes in the immune system at the patient level is essential. In this Review, we summarize the available clinical data, including forthcoming methods to assess the immune response to radiotherapy at the patient level, ranging from serum biomarkers to imaging techniques that enable investigation of immune cell dynamics in patients. Furthermore, we discuss modelling approaches that have been developed to predict the interaction of immunotherapy with radiotherapy, and highlight how they could be combined with biomarkers of antitumour immunity to optimize radiotherapy regimens and maximize their synergy with immunotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41571-019-0238-9

Cites

212 of 212 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Rittmeyer, A., Barlési, F., Waterkamp, D., Park, K., Ciardiello, F., von Pawel, J., Gadgeel, S. M., Hida, T., Kowalski, D. M., Cobo, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32517-x · Cited by 4,718
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809697 · Cited by 2,798
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434

Show all 216 references

Sorted by citations

Items 101–200 of 256

Progress of Immune Checkpoint Inhibitors Therapy for pMMR/MSS Metastatic Colorectal Cancer
Qu, F., Wu, S., & Yu, W. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s500281 · Cited by 20
Complete Pathologic Response After Concurrent Treatment with Pembrolizumab and Radiotherapy in Metastatic Colorectal Cancer: A Case Report
Yang, J., Bi, F., & Gou, H. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s298333 · Cited by 22
Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy
Li, J., Luo, Y., & Pu, K. (2020) · Angewandte Chemie · doi:10.1002/ange.202008386 · Cited by 19
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs
Tseng, I., Ai, D., Chen, Y., Zhu, H., Li, F., Xu, Y. Y., Yu, L., Liu, Q., Deng, J., Hao, S., et al. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02354-w · Cited by 19
Effect of Cumulative Dexamethasone Dose during Concomitant Chemoradiation on Lymphopenia in Patients with Newly Diagnosed Glioblastoma
Lee, C., Ahn, S., Park, J.-S., Song, J. H., Hong, Y.-K., & Jeun, S.-S. (2020) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2020.8.e12 · Cited by 20
Modeling Radioimmune Response—Current Status and Perspectives
Friedrich, T., Henthorn, N. T., & Durante, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.647272 · Cited by 19
Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer
Mulvey, A., Muggeo-Bertin, E., Berthold, D., & Herrera, F. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859785 · Cited by 18
Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma
Ahn, S., Park, J., Kim, H., Heo, M., Sung, Y. C., & Jeun, S. (2022) · Cancer Medicine · doi:10.1002/cam4.5467 · Cited by 18
Low-dose ionizing radiation promotes motor recovery and brain rewiring by resolving inflammatory response after brain injury and stroke
Au, N. P. B., Wu, T., Kumar, G., Jin, Y., Li, Y. Y. T., Chan, S. L., Lai, J. H. C., Chan, K. W. Y., Yu, K. N., Wang, X., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.015 · Cited by 21
A stochastic model of blood flow to calculate blood dose during radiotherapy
Beekman, C., Withrow, J. D., Correa-Alfonso, C. M., Pathak, S., Dawson, R. J., Carrasco-Rojas, N., Sforza, A. R., Colon, C. G., Bolch, W. E., Grassberger, C., et al. (2023) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad02d6 · Cited by 18
Self-citation
Normal Tissue Complication Probability Modeling of Severe Radiation-Induced Lymphopenia Using Blood Dose for Patients With Hepatocellular Carcinoma
Kim, S., Byun, H. K., Shin, J., Lee, I. J., & Sung, W. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.11.060 · Cited by 18
Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis
Naz, S., Leiker, A. J., Choudhuri, R., Preston, O., Sowers, A. L., Gohain, S., Gamson, J., Mathias, A., Waes, C. V., Cook, J. A., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.03.048 · Cited by 17
Novel emerging nano-assisted anti-cancer strategies based on the STING pathway
Li, X., Wang, H., Chen, Y., Li, Z., Liu, S., Guan, W., Lin, Y., Cao, C., Zheng, W., & Wu, J. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0023 · Cited by 17
Cancer Radiosensitization Nanoagent to Activate cGAS‐STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy
Wu, Z., Li, Q., Zhu, K., Zheng, S., Hu, H., Hou, M., Li, Q., Chen, S., Xu, Y., Zhao, B., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303626 · Cited by 18
A hydrogel-enabled cascade amplification of radiosensitization and immune activation for cancer radiotherapy
Song, Q., Lan, G., Li, Q., Lin, Y., Chen, X., Liu, H., Cheng, Y., & Luan, Y. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142201 · Cited by 16
Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases
Yan, X., Qu, F., & Zhou, Y. (2023) · Lung Cancer · doi:10.1016/j.lungcan.2023.107322 · Cited by 19
NLGN4X TCR transgenic T cells to treat gliomas
Krämer, C., Kilian, M., Chih, Y., Kourtesakis, A., Hoffmann, D. C., Boschert, T., Koopmann, P., Sanghvi, K., Roia, A. D., Jung, S., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad172 · Cited by 19
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy
Winter, S. F., Vaios, E., Shih, H. A., Grassberger, C., Parsons, M. W., Gardner, M. M., Ehret, F., Kaul, D., Boehmerle, W., Endres, M., et al. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01131-x · Cited by 15
Self-citation
Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors
Ji, X., Jiang, W., Wang, J., Zhou, B., Ding, W., Liu, S., Huang, H., Chen, G., & Sun, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1106644 · Cited by 18
Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response
Cheng, S., Cheadle, E. J., & Illidge, T. (2020) · Cancers · doi:10.3390/cancers12102835 · Cited by 18
Alkaline Adjuvant Regulates Proteolytic Activity of Macrophages for Antigen Cross‐Presentation and Potentiates Radioimmunotherapy
Li, B., Tan, Y. Q., Lei, J. H., Deng, M., Yu, X., Wang, X., Lei, L. M., Lin, H., Deng, C., & Dai, Y. (2025) · Advanced Materials · doi:10.1002/adma.202416690 · Cited by 15
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH)
Zhou, L., Sun, J., Xie, C., Kang, K., Yao, Z., Gong, Y., Huang, M., Wang, H., Wu, L., Yuan, Z., et al. (2025) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2025.06.3872 · Cited by 15
Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma
Grassberger, C., Shinnick, D. J., Yeap, B. Y., Tracy, M., Ellsworth, S. G., Hess, C. B., Weyman, E. A., Gallotto, S. L., Lawell, M. P., Bajaj, B. V. M., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.01.035 · Cited by 15
Self-citation
Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications
Helm, A., Fournier, C., & Durante, M. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.2 · Cited by 15
Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials
Tseng, I., Li, F., Ai, D., Chen, Y., Xu, Y. Y., Yu, L., Hao, S., Zhu, H., Deng, J., Liu, Q., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyad109 · Cited by 15
Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy via DNA damage enhancement
Ma, Y., Tang, X., Xu, Y., Jiang, W. J., Xin, Y., Zhao, W., He, X., Lu, L., & Zhan, M. (2021) · Biomaterials Science · doi:10.1039/d1bm00157d · Cited by 16
The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review
Heinzerling, J. H., Mileham, K. F., & Simone, C. B. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2241 · Cited by 14
Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy
Rounis, K., Skribek, M., Makrakis, D., Petris, L. D., Agelaki, S., Ekman, S., & Tsakonas, G. (2021) · Cancers · doi:10.3390/cancers13071562 · Cited by 14
Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review
Dar, T. B., Biteghe, F. A. N., Kakar, R., Aniogo, E. C., Malindi, Z., Akinrinmade, O. A., Chalomie, N. E. T., Kombe, A. J. K., Angone, S. A., Ndong, J. M. N., et al. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02888-7 · Cited by 14
Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy
Qian, X., Wang, Y., Xie, H., Wang, C., Li, J., Lei, Y., Liu, H., Wu, Y., Li, Y., & Zhang, Z. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.044 · Cited by 15
The societal impact of ion beam therapy
Bortfeld, T. R., de Viana, M. F., & Yan, S. (2020) · Zeitschrift für Medizinische Physik · doi:10.1016/j.zemedi.2020.06.007 · Cited by 14
Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
Hoffmann, E., Paulsen, F., Schaedle, P., Zips, D., Gani, C., Rammensee, H., Gouttefangeas, C., & Eckert, F. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03002-6 · Cited by 14
Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy
Chamseddine, I. M., Kim, Y., De, B. S., Naqa, I. E., Duda, D. G., Wolfgang, J. A., Pursley, J., Paganetti, H., Wo, J. Y.-L., Hong, T. S., et al. (2022) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00169 · Cited by 13
Self-citation
Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
Huang, R., Bi, Z., Hu, S., Zhang, Q., Su, X., & Zhang, W. (2023) · Biomarker Research · doi:10.1186/s40364-023-00478-5 · Cited by 15
Radiation therapy and immunotherapy in breast cancer treatment: preliminary data and perspectives
Cao, K. I., Abbassi, L., Romano, E., & Kirova, Y. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1868993 · Cited by 13
Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study
McDermott, R., Greene, J. P., McCaffrey, J., Parker, I., Helanova, S., Baird, A., Teiserskiene, A., Lim, M. C. J., Matthews, H. F., Deignan, O., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211042691 · Cited by 13
Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Liu, C., Zhang, Y., Gao, X., & Wang, G. (2023) · BMC Biology · doi:10.1186/s12915-023-01658-3 · Cited by 12
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer
Pavarini, M., Alborghetti, L., Aimonetto, S., Maggio, A., Landoni, V., Ferrari, P., Bianculli, A., Petrucci, E. T. F., Cicchetti, A., Farina, B., et al. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110230 · Cited by 12
Modelling radiobiology
Gardner, L. L., Thompson, S. J., O’Connor, J. D., & McMahon, S. J. (2024) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad70f0 · Cited by 12
Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction (SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial
Chuong, M. D., Mittauer, K. E., Bassetti, M. F., Rojas, C., Glide‐Hurst, C. K., Kalman, N. S., Tom, M. C., Rubens, M., Crosby, J., Burr, A., et al. (2025) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2025.03.030 · Cited by 12
Abscopal Response in Metastatic Melanoma: Real-World Data of a Retrospective, Multicenter Study
Ollivier, L., Orione, C., Bore, P., Misery, L., Legoupil, D., Leclere, J.-C., Coste, A., Girault, G., Sicard-Cras, I., Kacperek, C., et al. (2022) · Cancers · doi:10.3390/cancers14174213 · Cited by 12
Risk factors for late-onset Pneumocystis jirovecii pneumonia in liver transplant recipients
Min, E., Lee, J., Jeong, S. J., Kim, D. G., Yim, S. H., Choi, M. C., Joo, D. J., Kim, M. S., & Lee, J. G. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.04.387 · Cited by 14
The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review
Ollivier, L., Moreau-Bachelard, C., Renaud, E., Dhamelincourt, E., & Lucia, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1201675 · Cited by 12
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study
Sandhu, S., Joshua, A. M., Emmett, L., Bressel, M., Anton, A., Spain, L., Horvath, L. G., Pasam, A., Tolmeijer, S. H., Akhurst, T., et al. (2026) · The Lancet Oncology · doi:10.1016/s1470-2045(26)00017-3 · Cited by 13
Challenges in the combination of radiotherapy and immunotherapy for breast cancer
Zhang, R., Clark, S., Guo, B., Zhang, T., Jeansonne, D. P., Jeyaseelan, S., Francis, J., & Huang, W. (2023) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2023.2188196 · Cited by 11
Modeling of radiation effects to immune system: a review
Sung, W., & Cho, B. (2022) · Journal of the Korean Physical Society · doi:10.1007/s40042-022-00574-z · Cited by 12
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank
Lonie, J. M., Brosda, S., Bonazzi, V., Aoude, L. G., Patel, K., Brown, I., Sharma, S., Lampe, G., Addala, V., Koufariotis, L. T., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1220129 · Cited by 11
Quantification of Scheduling Impact on Safety and Efficacy Outcomes of Brain Metastasis Radio- and Immuno-Therapies: A Systematic Review and Meta-Analysis
Voronova, V., Lebedeva, S. A., Sekacheva, M. I., Helmlinger, G., & Peskov, K. V. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01609 · Cited by 12
Recent progresses on radiotherapeutics-based treatment of cancer with two-dimensional nanomaterials
Luo, G., Li, Z., Zheng, J., Yang, H., Li, X., Guishan, X., & Duo, Y. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101584 · Cited by 10
Research progress of metal–CpG composite nanoadjuvants in tumor immunotherapy
Chen, Y., Feng, D., Cheng, Y., Jiang, X., Qiu, L., Zhang, L., Shi, D., & Wang, J. (2025) · Biomaterials Science · doi:10.1039/d4bm01399a · Cited by 10
A “three musketeers” tactic for inclining interferon-γ as a comrade-in-arm to reinforce the synergistic-tumoricidal therapy
Li, W., Xie, L., Ju, Y., Zhang, Z., Li, B., Li, J., Sang, W., Wang, G., Tian, H., & Dai, Y. (2021) · Nano Research · doi:10.1007/s12274-021-3977-8 · Cited by 10
Progress in radiotherapy for small‐cell lung cancer
Yang, F., & Zhao, H. (2023) · Precision Radiation Oncology · doi:10.1002/pro6.1205 · Cited by 10
Modeling Resistance and Recurrence Patterns of Combined Targeted–Chemoradiotherapy Predicts Benefit of Shorter Induction Period
McClatchy, D. M., Willers, H., Hata, A. N., Piotrowska, Z., Sequist, L. V. D., Paganetti, H., & Grassberger, C. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3883 · Cited by 10
Self-citation
Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer
Kang, B.-H., Li, X., Son, J., Song, C., Kang, H., Kim, H. J., Wu, H., & Lee, J. H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891221 · Cited by 10
Manganese-enriched nanoboron agent amplifies BNCT efficacy via pyroptosis-mediated immune activation and STING pathway synergy
Zhang, Z., Sun, X., Qin, Y., Yang, Y., Dai, Q., Bao, X., Suzuki, M., Wang, S., Yang, Z., Li, Z., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03916-8 · Cited by 9
The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma
Li, J., Sun, J., Liu, Z., Zeng, Z., Ouyang, S., Zhang, Z., Ma, M., & Kang, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.862563 · Cited by 9
Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials
DuRoss, A. N., Phan, J., Lazar, A. J., Walker, J. M., Guimarães, A. R., Baas, C., Krishnan, S., Thomas, C. R., Sun, C., & Bagley, A. F. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1867 · Cited by 9
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
van Genugten, E. A. J., Weijers, J. A. M., Heskamp, S., Kneilling, M., van den Heuvel, M. M., Piet, B., Bussink, J., Hendriks, L. E. L., & Aarntzen, E. H. J. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.786089 · Cited by 9
Emerging mechanisms of triple-negative breast cancer radioresistance: Interplay between cancer cell mechanisms and the tumor immune microenvironment
Canha-Borges, A., Nunes, B., Quintas, S. T., Paredes, J., Meziani, L., Mondini, M., Oliveira, M. J., Deutsch, É., & Castro, F. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103026 · Cited by 10
Tumor cell-based vaccine contributes to local tumor irradiation by eliciting a tumor model-dependent systemic immune response
Remic, T., Serša, G., Levpuscek, K., Tratar, U. L., Uršič, K., Cör, A., & Kamenšek, U. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974912 · Cited by 8
Efficacy of radiotherapy in combination with first-line immunotherapy and chemotherapy for advanced lung squamous cell carcinoma: a propensity score analysis
Qin, J., Yi, S., Zhou, H., Zeng, C., Zou, M., Zeng, X., Yang, Z., & Huang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1138025 · Cited by 8
TGF-β1 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy
Han, L., Huang, X., Zhao, B., Zhu, H., Wang, R., Liu, S., Lin, H., Feng, F., Ma, X., Liu, F., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03479-3 · Cited by 8
Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy
Xie, B., & Luo, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.903781 · Cited by 9
Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination
Wu, W., Xu, H., Liao, C.-Y., Wang, Y., Wu, R., Wu, J., Zheng, W., Li, Y., Jin, C., Zhao, Y., et al. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00724-2 · Cited by 8
Targeting Apoptosis Inhibition to Activate Antitumor Immunity
Kesavardhana, S., & Kanneganti, T. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.11.002 · Cited by 8
Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer
Peng, Q., Tao, J., Xu, Y., Shen, Y., Wang, Y., Jiao, Y., Mao, Y., Zhu, Y., Liu, Y., & Tian, Y. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101828 · Cited by 7
Nanoradiosentizers with X ray-actuatable supramolecular aptamer building units for programmable immunostimulatory T cell engagement
He, J., Ren, X., Zhang, Q., Wang, S., Li, Z., Cai, K., Li, M., Hu, Y., Ran, Q., & Luo, Z. Y. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122924 · Cited by 7
Combined immune checkpoint inhibitors and ablative radiotherapy in metastatic cancers: a meta-analysis of prospective clinical trials
Urias, E., Lee, J., Weil, C. R., Roach, E. A., Lloyd, S. A. J., Hashibe, M., Facciabene, A., Maity, A. M., & Tao, R. (2025) · BMJ Oncology · doi:10.1136/bmjonc-2025-000732 · Cited by 9
X-ray activated platinum complex induces DNA damage and enhances cancer immunotherapy through abscopal effect
Chen, G., Li, X., Huang, Y., Zheng, C., Fang, H., Zhang, Q., Liu, K., Wu, K., Zhu, Q., Guo, C., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01612-y · Cited by 7
Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: A systematic review of the literature
Danckaert, W., Spaas, M., Vandecasteele, K., Wagter, C. D., & Ost, P. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.02.030 · Cited by 7
Prediction of radiosensitivity and radiocurability using a novel supervised artificial neural network
Zeng, Z., Luo, M., Li, Y., Li, J., Huang, Z., Zeng, Y., Yuan, Y., Wang, M., Liu, Y., Gong, Y. Q., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10339-3 · Cited by 7
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival
Nakamori, K., Yamazaki, S., Komura, K., Fukuokaya, W., Adachi, T., Hirasawa, Y., Hashimoto, T., Yoshizawa, A., Ohno, T., Yano, Y., et al. (2022) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2022.12.001 · Cited by 7
Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
Ng, S. S. W., & Dawson, L. A. (2022) · Biomedicines · doi:10.3390/biomedicines10123215 · Cited by 7
Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
Andersson, P., & Ostheimer, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02083 · Cited by 7
Mechanistic in silico explorations of the immunogenic and synergistic effects of radiotherapy and immunotherapy: a critical review
Ng, A. M., MacKinnon, K. M., Cook, A., D’Alonzo, R. A., Rowshanfarzad, P., Nowak, A. K., Gill, S., & Ebert, M. A. (2024) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-024-01458-1 · Cited by 6
Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer
Zschaeck, S., Zöphel, K., Seidlitz, A., Zips, D., Kotzerke, J., Baumann, M. A., Troost, E. G. C., Löck, S., & Krause, M. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.10.030 · Cited by 6
Dynamic changes in practical inflammation and immunity markers in cancer patients receiving immune-enhancing nutritional supplementation during concurrent chemoradiotherapy
Homkham, N., Muangwong, P., Pisprasert, V., Traisathit, P., Jiratrachu, R., Chottaweesak, P., & Chitapanarux, I. (2021) · Cancer Biomarkers · doi:10.3233/cbm-210086 · Cited by 6
In situ enzymatic peptide-based nanomedicine with combined effects for enhanced tumor radio-immunotherapy
Gao, T., Wang, Z., Zhou, J., Wang, D., Hou, X., Lin, X., Wang, Z., Chang, J., Liu, J., & Ren, C. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155437 · Cited by 6
IFNgamma-inducible CXCL10/CXCR3 axis alters the sensitivity of HEp-2 cells to ionizing radiation
Lin, Y., Lu, R., Hou, J., Zhou, G. G., & Fu, W. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112382 · Cited by 6
Failla Memorial Lecture: The Many Facets of Heavy-Ion Science
Durante, M. (2021) · Radiation Research · doi:10.1667/rade-21-00029.1 · Cited by 6
DNA Damage Repair in Brain Tumor Immunotherapy
Zhao, S., Xu, B., Ma, W., Chen, H., Jiang, C., Cai, J., & Meng, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.829268 · Cited by 6
Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future
Cheng, Z., Du, Y., Yu, L., Zhu, Y., & Tian, J. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01688-9 · Cited by 6
Irradiation immunity interactions
Davis, D. A. S., Atmosukarto, I. I., Garrett, J., Gosling, K. M., Syed, F. M., & Quah, B. (2022) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.13399 · Cited by 6
Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review
Rosenfeld, R., Sganga, S., Badalamenti, M., Mortellaro, S., Scorsetti, M., Garrone, O., Iannantuono, G. M., Chandran, E. B. A., Ghidini, M., & Franzese, C. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06245-3 · Cited by 5
Tumor Microenvironment Reprogramming via Copper-Enriched Black Phosphorus Nanoplatform for Cuproptosis-Sensitized Low-Dose Radioimmunotherapy
Chen, Y., Wang, J., Zheng, D., & Zhang, W. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s563439 · Cited by 5
Applicability of cCR assessment criteria in pMMR rectal cancer patients treated with neoadjuvant chemoradiotherapy combined with immunotherapy
Pei, J., Xu, H., Dong, Q., Gao, Y., Huang, Y., Xie, X., Huang, L., Qu, B., Chen, Y., Yang, S.-X., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002795 · Cited by 5
Impact of Radiation Therapy on Biological Parameters in Cancer Patients: Sub-analysis from the RIT Prospective Epidemiological Study
Magné, N., Daguenet, É., Bouleftour, W., Conraux, L., Tinquaut, F., Grangeon, K., Moreno‐Acosta, P., Suchaud, J.-P., Rancoule, C., & Guy, J. (2022) · Cancer Investigation · doi:10.1080/07357907.2022.2139838 · Cited by 5
In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model
Kim, Y., Jeon, S. H., Kim, S., Kang, M. H., Han, M. G., Lee, S. Y., & Kim, I. A. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110480 · Cited by 4
Survey of Changes in Absolute Lymphocyte Counts and Peripheral Immune Repertoire Diversity after External Beam Radiotherapy
Ellsworth, S. G., Ross, A., Shiue, K., Murthy, P., Byrne-Steele, M. L., Patel, R. B., Zellars, R. C., Kong, F., Miller, A., Russ, K. A., et al. (2024) · Radiation Research · doi:10.1667/rade-24-00010.1 · Cited by 4
Self-citation
International cost-effectiveness analysis of chemoradiotherapy plus pembrolizumab for locally advanced cervical cancer
Liu, K., Zhu, Y., & Zhu, H. (2025) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2025.36.e106 · Cited by 4
Modulating the tumor immune phenotypes by radiotherapy: formulating and validating the combination therapy of radiation, PD-L1, and TIM-3 blockade in colorectal cancer
Wang, X., Zhu, C., Sun, Y., Xie, X., Wang, M., Jin, Y., Gu, Y., Qian, L., Shi, L., Xu, J., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013656 · Cited by 4
Place de l’immunothérapie dans le cancer bronchique non à petites cellules localement avancé
Lévy, A., Doyen, J., Botticella, A., Bourdais, R., Achkar, S., Giraud, P., Du, C., Naltet, C., Lavaud, P., Besse, B., et al. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2019.09.007 · Cited by 4
Comprehensive screening for drugs that modify radiation-induced immune responses
Okumura, M., Du, J., Kageyama, S., Yamashita, R., Hakozaki, Y., Motegi, A., Hojo, H., Nakamura, M., Hirano, Y., Okuma, Y., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01688-0 · Cited by 4
Theranostic Radiolabeled Nanomaterials for Molecular Imaging and potential Immunomodulation Effects
Chen, C., Chan, Y., Lin, S.-L., Chiang, H. K., Lee, Y., & Chuang, H. (2022) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-022-00715-6 · Cited by 4
The differential immunological impact of photon vs proton radiation therapy in high-grade lymphopenia in patients with gastrointestinal tumors
Heather, J. M., Kim, D. W., Sepulveda, S. M., Seventer, E. E. V., Fish, M. G., Corcoran, R. B., Hacohen, N., Hong, T. S., & Cobbold, M. (2025) · Clinical & Experimental Immunology · doi:10.1093/cei/uxaf040 · Cited by 4
The Lymphatic Endothelium in the Context of Radioimmuno-Oncology
Suárez, L., Rodriguez-Ruiz, M. E., & Rouzaut, A. (2022) · Cancers · doi:10.3390/cancers15010021 · Cited by 3
Combining Radiation Therapy with Immune Checkpoint Blockadein Breast Cancer
Tabrizi, S., McDuff, S. G. R., & Ho, A. Y. (2019) · Current Breast Cancer Reports · doi:10.1007/s12609-019-00327-1 · Cited by 3
Effective dose to immune cells combined with platelet-to-lymphocyte ratio predicts lymphopenia and prognosis in unresectable locally advanced non-small cell lung cancer
Yang, H., Ma, J., Tian, C., Bao, S., Zhang, J., Wang, F., Xu, Y., Yu, J., & Chen, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1657972 · Cited by 2
BLOOD: A fast, customizable, and patient-specific computational framework for assessing whole-body lymphocyte dose, survival, and replenishment after radiotherapy treatments
López-Martínez, I. N., Espinoza, I., Muñoz, I., Muñoz-Schuffenegger, P., & Sánchez-Nieto, B. (2026) · Physica Medica · doi:10.1016/j.ejmp.2026.105771 · Cited by 2
Radiotherapy Models
Padmanabhan, R., Meskin, N., & Moustafa, A. A. (2020) · Series in bioengineering · doi:10.1007/978-981-15-8640-8_6 · Cited by 2

Authors: Grassberger, C., Ellsworth, S. G., Wilks, M. Q., Keane, F. K., & Loeffler, J. S.
Affiliations: Harvard University (US)
Indiana University School of Medicine (US)
Gordon Center for Medical Imaging (US)
Corresponding author: Grassberger, Clemens
ORCID: Grassberger, Clemens
Ellsworth, Susannah G.
Keane, Florence K.
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2019-06-26
Volume: 16
Issue: 12
Pages: 729-745
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/s41571-019-0238-9
PMC: PMC13492067
OpenAlex: W2954542121
Cited by: 244
References: 216
Citations by year: 2026: 14 · 2025: 26 · 2024: 25 · 2023: 45 · 2022: 53 · 2021: 36 · 2020: 40 · 2019: 5
FWCI: 3.19
Type: journal article
Language: en
Open access: green
pmc.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (submittedVersion)
Funders: Massachusetts General Hospital
National Cancer Institute (R21CA241918, P01CA021239)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Keywords: radiotherapy, antitumor immunity, immune checkpoint inhibitors, radiation-induced immunosuppression, immune response assessment, serum biomarkers, immune cell imaging, personalized radiotherapy, predictive biomarkers
MeSH terms: Combined Modality Therapy, Humans, Immune System, Immunotherapy, Neoplasms, Radiotherapy, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessing the interactions between radiotherapy and antitumour immunity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks